company background image
603229 logo

Zhejiang Ausun Pharmaceutical SHSE:603229 Stock Report

Last Price

CN¥10.45

Market Cap

CN¥6.2b

7D

-7.4%

1Y

-38.3%

Updated

25 Mar, 2024

Data

Company Financials +

Zhejiang Ausun Pharmaceutical Co., Ltd.

SHSE:603229 Stock Report

Market Cap: CN¥6.2b

603229 Stock Overview

Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates.

603229 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth6/6
Past Performance3/6
Financial Health5/6
Dividends2/6

Zhejiang Ausun Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Ausun Pharmaceutical
Historical stock prices
Current Share PriceCN¥10.45
52 Week HighCN¥17.47
52 Week LowCN¥8.06
Beta0.0095
1 Month Change-1.79%
3 Month Change-17.52%
1 Year Change-38.35%
3 Year Change-31.73%
5 Year Change119.17%
Change since IPO205.86%

Recent News & Updates

Improved Earnings Required Before Zhejiang Ausun Pharmaceutical Co., Ltd. (SHSE:603229) Stock's 27% Jump Looks Justified

Mar 06
Improved Earnings Required Before Zhejiang Ausun Pharmaceutical Co., Ltd. (SHSE:603229) Stock's 27% Jump Looks Justified

Recent updates

Improved Earnings Required Before Zhejiang Ausun Pharmaceutical Co., Ltd. (SHSE:603229) Stock's 27% Jump Looks Justified

Mar 06
Improved Earnings Required Before Zhejiang Ausun Pharmaceutical Co., Ltd. (SHSE:603229) Stock's 27% Jump Looks Justified

Shareholder Returns

603229CN PharmaceuticalsCN Market
7D-7.4%-1.6%-0.03%
1Y-38.3%-8.6%-14.2%

Return vs Industry: 603229 underperformed the CN Pharmaceuticals industry which returned -8.6% over the past year.

Return vs Market: 603229 underperformed the CN Market which returned -14.2% over the past year.

Price Volatility

Is 603229's price volatile compared to industry and market?
603229 volatility
603229 Average Weekly Movement6.8%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement8.1%
10% most volatile stocks in CN Market11.3%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 603229's share price has been volatile over the past 3 months.

Volatility Over Time: 603229's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20101,129Zhiguo Zhenghttps://www.ausunpharm.com

Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications.

Zhejiang Ausun Pharmaceutical Co., Ltd. Fundamentals Summary

How do Zhejiang Ausun Pharmaceutical's earnings and revenue compare to its market cap?
603229 fundamental statistics
Market capCN¥6.20b
Earnings (TTM)CN¥283.64m
Revenue (TTM)CN¥858.30m

21.9x

P/E Ratio

7.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603229 income statement (TTM)
RevenueCN¥858.30m
Cost of RevenueCN¥371.69m
Gross ProfitCN¥486.60m
Other ExpensesCN¥202.97m
EarningsCN¥283.64m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 27, 2024

Earnings per share (EPS)0.48
Gross Margin56.69%
Net Profit Margin33.05%
Debt/Equity Ratio14.7%

How did 603229 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

16%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.